Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 35, 2023 - Issue 8
177
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cannabis use frequency and pain interference among people with HIV

ORCID Icon, , , , , ORCID Icon, ORCID Icon, , & show all
Pages 1235-1242 | Received 22 Aug 2022, Accepted 21 Apr 2023, Published online: 18 May 2023

References

  • Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007). Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology, 68(7), 515–521. https://doi.org/10.1212/01.wnl.0000253187.66183.9c
  • Addis, D. R., DeBerry, J. J., & Aggarwal, S. (2020). Chronic pain in HIV. Molecular Pain, 16, 1744806920927276. https://doi.org/10.1177/1744806920927276
  • Atkinson, T. M., Rosenfeld, B. D., Sit, L., Mendoza, T. R., Fruscione, M., Lavene, D., Shaw, M., Li, Y., Hay, J., Cleeland, C. S., Scher, H. I., Breitbart, W. S., & Basch, E. (2011). Using confirmatory factor analysis to evaluate construct validity of the brief pain inventory (BPI). Journal of Pain and Symptom Management, 41(3), 558–565. https://doi.org/10.1016/j.jpainsymman.2010.05.008
  • Becker, W. C., Li, Y., Caniglia, E. C., Vickers-Smith, R., Feinberg, T., Marshall, B. D. L., & Edelman, E. J. (2022). Cannabis use, pain interference, and prescription opioid receipt among persons with HIV: A target trial emulation study. AIDS Care, 34(4), 469–477. https://doi.org/10.1080/09540121.2021.1944597
  • Bruce, R. D., Merlin, J., Lum, P. J., Ahmed, E., Alexander, C., Corbett, A. H., Foley, K., Leonard, K., Treisman, G. J., & Selwyn, P. (2017). HIVMA of IDSA clinical practice guideline for the management of chronic pain in patients living with HIV. Clinical Infectious Diseases, 65(10), e1–e37. https://doi.org/10.1093/cid/cix636
  • Campbell, G., Hall, W. D., Peacock, A., Lintzeris, N., Bruno, R., Larance, B., Nielsen, S., Cohen, M., Chan, G., Mattick, R. P., Blyth, F., Shanahan, M., Dobbins, T., Farrell, M., & Degenhardt, L. (2018). Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. Lancet Public Health, 3(7), e341–e350. https://doi.org/10.1016/S2468-2667(18)30110-5
  • Campbell-Sills, L., Norman, S. B., Craske, M. G., Sullivan, G., Lang, A. J., Chavira, D. A., Bystritsky, A., Sherbourne, C., Roy-Byrne, P., & Stein, M. B. (2009). Validation of a brief measure of anxiety-related severity and impairment: The overall anxiety severity and impairment scale (OASIS). Journal of Affective Disorders, 112(1-3), 92–101. https://doi.org/10.1016/j.jad.2008.03.014
  • Eibach, L., Scheffel, S., Cardebring, M., Lettau, M., Özgür Celik, M., Morguet, A., Roehle, R., & Stein, C. (2021). Cannabidivarin for HIV-associated neuropathic pain: A randomized, blinded, controlled clinical trial. Clinical Pharmacology and Therapeutics, 109(4), 1055–1062. https://doi.org/10.1002/cpt.2016
  • Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J. H. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial. Neuropsychopharmacology, 34(3), 672–680. https://doi.org/10.1038/npp.2008.120
  • Fairchild, A. J., & MacKinnon, D. P. (2009). A general model for testing mediation and moderation effects. Prevention Science, 10(2), 87–99. https://doi.org/10.1007/s11121-008-0109-6
  • Fleet, J. L., Dixon, S. N., Kuwornu, P. J., Dev, V. K., Montero-Odasso, M., Burneo, J., & Garg, A. X. (2018). Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study. PLoS ONE, 13(3), e0193134. https://doi.org/10.1371/journal.pone.0193134
  • Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. Lancet, 374(9698), 1383–1391. https://doi.org/10.1016/S0140-6736(09)61037-0
  • Hartzler, B., Dombrowski, J. C., Crane, H. M., Eron, J. J., Geng, E. H., Christopher Mathews, W., Mayer, K. H., Moore, R. D., Mugavero, M. J., Napravnik, S., Rodriguez, B., & Donovan, D. M. (2017). Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS and Behavior, 21(4), 1138–1148. https://doi.org/10.1007/s10461-016-1584-6
  • Hill, K. P. (2019). Medical use of cannabis in 2019. JAMA, 322(10), 974–975. https://doi.org/10.1001/jama.2019.11868
  • Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., Weissman, S., Neidig, J., Marcus, C., Chesney, M., Cohn, S. E., & Wu, A. W. (2001). Adult AIDS clinical trials unit outcomes committee. Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54(Suppl 1), S77–S90. https://doi.org/10.1016/s0895-4356(01)00449-8
  • Kim, T. W., Walley, A. Y., Heeren, T. C., Patts, G. J., Ventura, A. S., Lerner, G. B., Mauricio, N., & Saitz, R. (2017). Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence. Journal of Substance Abuse Treatment, https://doi.org/10.1016/j.jsat.2017.07.007
  • Larue, F., Fontaine, A., & Colleau, S. M. (1997). Underestimation and undertreatment of pain in HIV disease: Multicentre study. BMJ, 314(7073), 23–28. https://doi.org/10.1136/bmj.314.7073.23
  • Martinez-Calderon, J., Flores-Cortes, M., Clavero-Cano, S., Morales-Asencio, J. M., Jensen, M. P., Rondon-Ramos, A., Diaz-Cerrillo, J. L., Ariza-Hurtado, G. R., & Luque-Suarez, A. (2020). The role of positive psychological factors in the association between pain intensity and pain interference in individuals with chronic musculoskeletal pain: A cross-sectional study. Journal of Clinical Medicine, 9(10), 3252. https://doi.org/10.3390/jcm9103252
  • McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., & Argeriou, M. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9(3), 199–213. https://doi.org/10.1016/0740-5472(92)90062-s
  • Merlin, J. S., Long, D., Becker, W. C., Cachay, E. R., Christopoulos, K. A., Claborn, K., Crane, H. M., Edelman, E. J., Harding, R., Kertesz, S. G., Liebschutz, J. M., Mathews, W. C., Mugavero, M. J., Napravnik, S., O'Cleirigh, C., Saag, M. S., Starrels, J. L., & Gross, R. (2018). Brief report: The association of chronic pain and long-term opioid therapy with HIV treatment outcomes. Journal of Acquired Immunodeficiency Syndrome, 79(1), 77–82. https://doi.org/10.1097/QAI.0000000000001741
  • Miaskowski, C., Penko, J. M., Guzman, D., Mattson, J. E., Bangsberg, D. R., & Kushel, M. B. (2011). Occurrence and characteristics of chronic pain in a community-based cohort of indigent adults living with HIV infection. Journal of Pain, 12(9), 1004–1016. https://doi.org/10.1016/j.jpain.2011.04.002
  • National Academies of Sciences, Engineering, and Medicine. (2017). The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. The National Academies Press. https://doi.org/10.17226/24625
  • New York State Department of Health Announces Opioid Replacement Now a Qualifying Condition for Medical Marijuana. (2018, July 12). New York State Department of Health. Retrieved 2022, from https://health.ny.gov/press/releases/2018/2018-07-12_opioid_replacement.htm
  • Saitz, R., Mesic, A., Ventura, A. S., Winter, M. R., Heeren, T. C., Sullivan, M. M., Walley, A. Y., Patts, G. J., Meli, S. M., Holick, M. F., Kim, T. W., Bryant, K. J., & Samet, J. H. (2018). Alcohol consumption and bone mineral density in people with HIV and substance use disorder: A prospective cohort study. Alcoholism: Clinical and Experimental Research, https://doi.org/10.1111/acer.13801
  • Selim, A. J., Rogers, W., Fleishman, J. A., Qian, S. X., Fincke, B. G., Rothendler, J. A., & Kazis, L. E. (2009). Updated US population standard for the Veterans RAND 12-item Health Survey (VR-12). Quality of Life Research, 18(1), 43–52. https://doi.org/10.1007/s11136-008-9418-2
  • Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59(Suppl 20), 22–33. quiz 34-57.
  • Shover, C. L., Davis, C. S., Gordon, S. C., & Humphreys, K. (2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proceedings of the National Academy of Sciences of the United States of America, 116(26), 12624–12626. https://doi.org/10.1073/pnas.1903434116
  • Stockings, E., Campbell, G., Hall, W. D., Nielsen, S., Zagic, D., Rahman, R., Murnion, B., Farrell, M., Weier, M., & Degenhardt, L. (2018). Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions: A systematic review and meta-analysis of controlled and observational studies. Pain, 159(10), 1932–1954. https://doi.org/10.1097/j.pain.0000000000001293
  • Tan, G., Jensen, M. P., Thornby, J. I., & Shanti, B. F. (2004). Validation of the brief pain inventory for chronic nonmalignant pain. The Journal of Pain, 5(2), 133–137. https://doi.org/10.1016/j.jpain.2003.12.005
  • Tsui, J. I., Cheng, D. M., Coleman, S. M., Lira, M. C., Blokhina, E., Bridden, C., Krupitsky, E., & Samet, J. H. (2014). Pain is associated with risky drinking over time among HIV-infected persons in St. Petersburg, Russia. Drug and Alcohol Dependence, 144, 87–92. https://doi.org/10.1016/j.drugalcdep.2014.08.013
  • Valeri, L., & VanderWeele, T. J. (2013). Mediation analysis allowing for exposure-mediator interactions and causal interpretation: Theoretical assumptions and implementation with SAS and SPSS macros. Psychological Methods, 18(2), 137–150. https://doi.org/10.1037/a0031034
  • Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29(4), 358–367. https://doi.org/10.1016/j.jpainsymman.2004.07.011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.